-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse StuttgartEURSymbol 22UA-
BioNTechBörse Börse FrankfurtWKNEURSymbol 22UA
-
BioNTechBörse Xetra FrankfurtEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse BerlinEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse MünchenEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse StuttgartEURSymbol 22UA
-
BIONTECH SE-ADRBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse HamburgEURSymbol 22UA
-
BIONTECH SE-ADRBörse Quotrix System der Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Gettex System der Börse MünchenEURSymbol 22UA
-
ISIN US09075V1026 WKN: A2PSR2USDSymbol BNTX
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US09075V1026
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
BioNTech SEBörse London Stock Exchange
-
Symbol 22UA
Währung
EUR
Börse
Börse Stuttgart Zeitzone: Europe/Berlin
Firmenname
BioNTech SE
Marktkapitalisierung
26.221.596.672
Mitarbeiter
3.165 (+- 43%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.800 oder 4.530 Mitarbeiter
KGV
-99999.99
EBITDA 0
PEGRatio None
Buchwert None
Letzte Communitymeinungen
- 5 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
SaLyn
14.09.2021
-
Karamellsaus_55
29.08.2021
-
Zockrat
29.08.2021
Ein User hat BioNTech abonniert.
Aktionärsstruktur der BioNTech SE
Portrait der BioNTech Aktie
Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.
Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.
5 ETFs die in BioNTech investieren
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
365 News & Informationen zur BioNTech Aktie
US Covid-19 booster rollout to begin only with Pfizer vaccine: Report
Moderna's booster submission was found inadequate and the US FDA requires stronger data from the company, making the process likely to be a few weeks behind that of Pfizer-BioNTech
Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies
Celsion (CLSN) announces data from pre-clinical studies for its investigational vaccine platform as a potential treatment for COVID-19.
U.S. COVID-19 booster rollout to initially proceed with just Pfizer vaccine: Sources
Moderna Inc's booster submission was found inadequate and the U.S. Food and Drug Administration requires stronger data from the company, making the process likely to be a few weeks behind that of Pfizer/BioNTech, the source added.
Government health officials tell White House to scale back booster plan: NYT
Government health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans later in…
Three Doses Could Become Standard Covid Regimen, Fauci Says
(Bloomberg) — Three doses of Covid-19 vaccine may become the standard regimen for most people, White House chief medical adviser Anthony Fauci said Thursday at a briefing.
10 Best-Performing Countries for COVID-19 Vaccinations
In this article, we will list the 10 best-performing countries for COVID-19 vaccinations.
Rich Asians jump booster shot queue, put 'entire community at risk'
Read more about Rich Asians jump booster shot queue, put 'entire community at risk' on Business Standard. The growing trend in countries like Indonesia, Thailand and the Philippines is worsening inequities at a time when they are grappling with vaccine shortages
FDA committee to discuss COVID-19 booster shots
An influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the…
Moderna Asks FDA to Approve Covid Booster Shot
Moderna shares rose Thursday after the company asked the FDA to approve use of a third, or booster, shot of its Covid-19 vaccine.
Moderna seeks U.S. authorization for COVID-19 vaccine booster
Moderna Inc on Wednesday asked the U.S. Food and Drug Administration (FDA) to allow the use of a third booster dose of its COVID-19 vaccine.
Majority of U.S. companies may mandate COVID-19 vaccine in coming months
Majority of U.S. companies may mandate COVID-19 vaccine in coming months – survey
WHO identifies new coronavirus ‘variant of interest’ and experts urge caution on boosters
The World Health Organization said a strain of the coronavirus that causes COVID-19 and that was first detected in Colombia in January has become a “variant…
The debate over COVID-19 booster shots picks up steam. Will they be limited to certain high-risk Americans?
One Wall Street analyst thinks that COVID-19 booster shots will only be available to people at higher risk of cases of COVID-19, and not all vaccinated…
5 Top Picks to Boost Portfolio in Historically Weak September
We have narrowed down our search to five stocks that have provided more than 20% returns year to date. These are: DKS, KSS, ANF, RCII and HPQ.
Taking a third shot of the Pfizer vaccine
A third shot of the Pfizer Inc-BioNTech SE Covid vaccine provides added protection against the coronavirus during a delta outbreak, according to early data from…
4 Coronavirus Stocks That Are Still Worth Buying By StockNews
4 Coronavirus Stocks That Are Still Worth Buying
Vaccine hesitancy falls to lowest level since start of coronavirus pandemic in new poll, but more Americans still need to be persuaded
Fewer American adults than ever say they will not get vaccinated against the coronavirus that causes COVID-19 and more than ever plan to get children below…
Two FDA Vaccine Officials to Step Down After Covid Clearances
(Bloomberg) — Two key vaccine officials are preparing to step down from the U.S. Food and Drug Administration, which raced to clear Covid shots to fight the pandemic and is now considering President Joe Biden’s booster plan.
Two Senior FDA Officials Stepping Down Over Reported Disagreements With White House Over Booster Shots
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Glaxo, SK Bioscience Start Final Testing of Covid-19 Vaccine
(Bloomberg) — GlaxoSmithKline Plc said it’s starting a final stage clinical trial on a Covid-19 vaccine candidate designed by South Korean drugmaker SK Bioscience Co.
U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval
An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech SE COVID-19…
U.S. CDC advisers vote in favor of Pfizer/BioNTech vaccine after full approval
An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech Se COVID-19…
Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters
(Bloomberg) — The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.
US stocks climb to record highs as investors mull Powell's cautious outlook on the economy
A stock trader claps at the end of trade at the New York Stock Exchange EMMANUEL DUNAND/AFP via Getty Images US stocks jumped to new records M…
Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters By Bloomberg
Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters
Foxconn founder Terry Gou asks BioNTech to reserve 30 mn more Covid vaccines for Taiwan
Taiwan's quest to access the vaccine, jointly developed with Pfizer Inc, has dragged on for months, hampered by accusations from Taipei of political interference from Beijing, which claims the island as Chinese territory. Beijing has denied the allegations.
Covid-19 Boosters Work at Curbing Severe Cases, Israel Data Show
(Bloomberg) — A third Covid vaccination shot appeared to significantly curb a delta-led surge in cases and prevent severe illness, according to a study in Israel, the first country to offer boosters to seniors.
Twelve days or more after a booster dose of vaccine made by Pfizer Inc.
Japan May Consider Mixing Covid Shots for Speedier Vaccinations
(Bloomberg) — Japan could mix AstraZeneca Plc’s Covid-19 shots with those developed by other companies in order to speed up its vaccination effort, according…
Delta Air Lines, Airbnb, Peloton: Stocks That Defined the Week
Here are seven major companies whose stocks moved on the week’s news.
Kraft Heinz to mandate COVID-19 vaccines for office employees By Reuters
Kraft Heinz to mandate COVID-19 vaccines for office employees
Florida Mask Ban Blocked; Boosters May Start Early: Virus Update
(Bloomberg) — A judge blocked Florida from enforcing Governor Ron DeSantis’s ban on mask mandates in schools, clearing the way for educators to require face…
BioNTech : Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older (Form 6-K)
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
… | August 27, 2021
Blood clot risk much higher from Covid-19 than with vaccines
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc’s shots, according to a large UK…
Blood Clot Risk Much Higher From Covid-19 Than With Vaccines
(Bloomberg) — Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.’s shots, according to a large U.K. study.
Singapore stocks fall as investors shun risk ahead of Jackson Hole
Taiwanese stocks extended their winning
Blood clot risk much higher from Covid-19 than with vaccines — UK study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.’s shots, according to a large U.K. study.
Pfizer's Covid Technology May Have Cancer Applications
GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers
U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January
The number of COVID-19 hospitalizations in the U.S. has been slowly ticking up, and new data shows that 100,000 people are currently hospitalized with…